Wesana Health Granted US FDA Pre-IND Meeting for SANA-013
The majority of patients with traumatic brain injury (TBI) also experience depression, and patients with severe TBI-related depression are 5x more likely to attempt suicide.
Wesana Health (WESA) is planning a study to see if the condition can be treated with one large dose of psilocybin in a clinic, followed by “self-administered maintenance doses” of psilocybin and CBD to sustain the benefits.
Researchers believe the treatment will promote neuroplasticity and neurogenesis while reducing neuroinflammation.
